Skip to main content
PMC home page
Euroasian Journal of Hepato-Gastroenterology logoLink to Euroasian Journal of Hepato-Gastroenterology
. 2015 Jan 6;5(1):49–51. doi: 10.5005/jp-journals-10018-1130

Epidemiology of Hepatitis B and C Virus Infections and Liver Cancer in Vietnam

Son Huy Do 1,✉
PMCID: PMC5578521  PMID: 29201687

Abstract

Vietnam has been a highly endemic country of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections with high hepatitis B surface antigen (HBsAg) rate (8.8-19.0%) and high anti-HCV rate (1.0-3.3%) among general population. High mortality rates of liver cancer were also estimated from 14.8 to 23.7 per 100,000. Recently, the coverage of universal HB vaccination for infants has not been high as expected while there have been no other national programs against HBV and HCV infections yet. The burden of HBV and HCV-related diseases is predicted to remain a significant health problem in next decade.

How to cite this article

Do SH. Epidemiology of Hepatitis B and C Virus Infections and Liver Cancer in Vietnam. Euroasian J Hepato-Gastroenterol 2015;5(1):49-51.

Keywords: Epidemiology, Hepatitis B virus, Hepatitis C virus, Liver cancer, Vietnam.

INTRODUCTION

In 2012, International Agency for Research on Cancer, World Health Organization (WHO)1 estimated that Vietnam was one of the countries with the highest mortality from liver cancer, which is mostly attributed to persistent infections with hepatitis B virus (HBV) and hepatitis C virus (HCV).2 As there has been neither nationwide study nor national registration system in viral hepatitis and liver cancer, recent published researches in different regions of Vietnam play an important role in partly clarifying epidemiological characteristics of HBV and HCV infections as well as liver cancer in this country.

HEPATITIS B VIRUS INFECTION

In accordance with an estimation of WHO,3 prevalence of hepatitis B surface antigen (HBsAg) in Vietnam was as high as 8% or over, some population-based studies in different provinces in northern Vietnam found HBsAg rates of 18.8,4 19.05 and 8.8%.6 Recently, a sero-epidemiological research7 with randomly sampled participants among general population in Binh Thuan Province, southern Vietnam revealed a high HBsAg rate of 15.3% and particularly high rate of hepatitis B core antibody (HBcAb) of 71.7%. Taken together, these evidences indicate that Vietnam is a highly endemic country of HBV infection. Furthermore, persistent HBV infection was predicted to remain endemic in next decade, despite the achievement of the universal HB vaccination program for infants.8 While no difference in HBV infection rate between genders was found, HBV exposure (i.e. the positivity for HBsAg and/or HBc Ab) was observed significantly higher with increased age groups.5-7 Although various HBsAg rates were shown in different regions of Vietnam, no obvious trend of regional distribution of HBV infection in this country was reported.

As for HBV genotypic distribution in Vietnam, recent study among general population found that the most common HBV genotype was B (75.3%), followed by C (11.7%).7 Comparable distribution of genotypes B and C were also observed.9,10 However, other hospital-based researches showed the predominance of genotype C11,12 among patients with HBV infection. It was reported that genotype B was common among asymptomatic HBV-infected cases while genotype C was predominant in patients with liver cirrhosis and hepatocellular carcinoma (HCC).13 Thus, different study population might be one of the reasons why different HBV genotypic distributions were found in Vietnam.

It was well-known that the main route of HBV infection in endemic countries was mother-to-child transmission, followed by horizontal transmission during early childhood.14 Interestingly, horizontal HBV transmission was supposed to be more frequent than previously thought in Vietnam.7

HEPATITIS C VIRUS INFECTION

Epidemiological data on HCV infection in Vietnam might be even more limited than that of HBV infection. Prevalence of HCV infection in Vietnam was recently estimated as 2%15 while an earlier study found an anti-HCV rate of 1°% in northern Vietnam.16 However, in 2012, a higher rate of anti-HCV of 3.3% was revealed among general population in southern Vietnam.7 The most updated data were in concordance with the current report of Center for Disease Control and Prevention of United State that prevalence of HCV infection Vietnam is as high as 2.0 to 2.9%.17 No significant difference in HCV infection rate between genders was reported7,16 whereas age groups of 50 or over were found to have high-risk of anti-HCV seropositivity.7

Some studies on HCV genotypic distribution in Vietnam also showed different results. A study of 2000 HCV RNA positive samples from many hospitals in Ho Chi Minh city18 reported that genotype 1b was the most common (58%), followed by genotype 6a (17%). By contrast, other studies showed the predominance of genotype 6a among blood donors (37.1%)19 and among general population (55.6%).7 This discrepancy might be explained by the fact that HCV genotype 1b is more related to progressive liver diseases in comparison with other HCV genotypes.20

LIVER CANCER

Liver cancer has been the most frequent cause of cancer death in Vietnam.1 High mortality rates of liver cancer were reported from 14.8 to 23.7 per 100,000.1,21,22

In South-east Asian Region, where Vietnam belongs to, it was estimated that 65 and 18% of HCC cases were caused by persistent infection with HBV and HCV respectively 2. A study in central Vietnam showed that approximately 90% of patients with HCC had evidence of HBV, and one-seventh of them were related to HCV.15 Although published studies on relationship between HCC and HBV and/or HCV infection in Vietnam are rare, HBV and HCV have been considered the most important etiology of HCC in Vietnam.

So far, there has been regrettably no nationwide comprehensive approach to the HBV and HCV-related liver diseases, including HCC, in Vietnam15 except the universal HB vaccination program for infants started since 2002. Unfortunately, the coverage of HB vaccination has fluctuated and dropped to under 60% in 2013.23 Hence, to reduce the burden of HBV and HCV-related liver diseases, it is crucial to raise the coverage of the universal HB vaccination for infants as well as to promote other preventive measures against horizontal transmission of both HBV and HCV.

Footnotes

Source of support: Nil

Conflict of interest: None

REFERENCES

  • 1.WHO. International Agency for Research on Cancer. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide 2012 Available at: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
  • 2.Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006 Oct;45(4):529–538. doi: 10.1016/j.jhep.2006.05.013. [DOI] [PubMed] [Google Scholar]
  • 3.WHO. Department of Communicable Diseases Surveillance and Response. Hepatitis B 2002 WHO/CDS/CSR/LYO/20022: Hepatitis B Available at: http://www.who.int/csr/disease/hepatitis/HepatitisB_whocdscsrlyo2002_2.pdf.
  • 4.Hipgrave DB, Nguyen TV, Vu MH et al. Hepatitis B infection in rural Vietnam and the implications for a national program of infant immunization. Am J Trop Med Hyg. 2003 Sep;69(3):288–294. [PubMed] [Google Scholar]
  • 5.Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol. 2007 Dec;22(12):2093–2100. doi: 10.1111/j.1440-1746.2007.05010.x. [DOI] [PubMed] [Google Scholar]
  • 6.Duong TH, Nguyen PH, Henley K, Peters M. Risk factors for hepatitis B infection in rural Vietnam. Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):97–102. [PMC free article] [PubMed] [Google Scholar]
  • 7.Do SH, Yamada H, Fujimoto M et al. High prevalences of hepatitis B and C virus infections among adults living in Binh Thuan province, Vietnam. Hepatol Res. 2015 Mar;45(3):259–268. doi: 10.1111/hepr.12350. [DOI] [PubMed] [Google Scholar]
  • 8.Nguyen VT, Law MG, Dore GJ. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int. 2008 Apr;28(4):525–531. doi: 10.1111/j.1478-3231.2007.01646.x. [DOI] [PubMed] [Google Scholar]
  • 9.Hayashi K, Katano Y, Chuong TX et al. Prevalence of hepatitis B virus subgenotypes and basal core promoter, precore variants in patients with acute hepatitis B in central Vietnam. Intervirology. 2009;52(1):22–28. doi: 10.1159/000210835. [DOI] [PubMed] [Google Scholar]
  • 10.Huy TT, Ushijima H, Quang VX et al. Characteristics of core promoter and precore stop codon mutants of hepatitis B virus in Vietnam. J Med Virol. 2004 Oct;74(2):228–236. doi: 10.1002/jmv.20175. [DOI] [PubMed] [Google Scholar]
  • 11.Toan NL, Song LH, Kremsner PG et al. Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology. 2006 Jun;43(6):1375–1384. doi: 10.1002/hep.21188. [DOI] [PubMed] [Google Scholar]
  • 12.Tran HT, Ushijima H, Quang VX et al. Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res. 2003 Aug;26(4):275–280. doi: 10.1016/s1386-6346(03)00166-9. [DOI] [PubMed] [Google Scholar]
  • 13.Kao J, Chen D. HBV genotypes: epidemiology and implications regarding natural history. Current Hepatitis Reports. 2006;5(1):5–13. [Google Scholar]
  • 14.Merican I, Guan R, Amarapuka D et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000 Dec;15(12):1356–1361. doi: 10.1046/j.1440-1746.2000.0150121356.x. [DOI] [PubMed] [Google Scholar]
  • 15.Gish RG, Bui TD, Nguyen CT et al. Liver disease in Vietnam: screening, surveillance, management and education: a 5-year plan and call to action. J Gastroenterol Hepatol. 2012 Feb;27(2):238–247. doi: 10.1111/j.1440-1746.2011.06974.x. [DOI] [PubMed] [Google Scholar]
  • 16.Nguyen VT, McLaws ML, Dore GJ. Prevalence and risk factors for hepatitis C infection in rural north Vietnam. Hepatol Int. 2007 Sep;1(3):387–393. doi: 10.1007/s12072-007-9008-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Centers for Disease Control and Prevention. United States. Hepatitis C Available at: http://wwwnc.cdc.gov/travel/yellowbook/2014/chapter-3-infectious-diseases-related-totravel/hepatitis-c.
  • 18.Nguyen TB, Pham HV. Apply the direct sequencing of the qPCR products to do the HCV genotyping. Y Hoc TP Ho Chi Minh. 2009;13:243–249. [Google Scholar]
  • 19.Pham DA, Leuangwutiwong P, Jittmittraphap A, Luplert-lop N, Bach HK, Akkarathamrongsin S, Theamboonlers A, Poovorawan Y. High prevalence of hepatitis C virus genotype 6 in Vietnam. Asian Pac J Allerry Immunol. 2009 Jun-Sep;27(2-3):153–160. [PubMed] [Google Scholar]
  • 20.Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev. 2000 Apr;13(2):223–235. doi: 10.1128/cmr.13.2.223-235.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ngoan Ie T, Lua NT, Hang LT. Cancer mortality pattern in Vietnam. Asian Pacific J Cancer Prev. 2007 Oct-Dec;8(4):535–538. [PubMed] [Google Scholar]
  • 22.Hoa NP, Rao C, Hoy DG, Hinh ND, Chuc NT, Ngo DA. Mortality measures from sample-based surveillance: evidence of the epidemiological transition in Viet Nam. Bull World Health Organ. 2012 Oct 1;90(10):764–772. doi: 10.2471/BLT.11.100750. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.WHO. WHO vaccine-preventable diseases: monitoring system. 2014 global summary. Available at: http://apps.who.int/immunization_monitoring/globalsummary/countries?_countrycriteria%5Bcountry%5D%5B%5D=VNM.

Articles from Euroasian Journal of Hepato-Gastroenterology are provided here courtesy of Jaypee Brothers Medical Publishing (P) Ltd.

RESOURCES